Reference
Takezako N, et al. Biosimilar Filgrastim for the Prevention of Febrile Neutropenia in Elderly DLBCL Patients Has Cost Effectiveness Compared with Original Filgrastim. 20th Congress of the European Haematology Association : abstr. E1454, 11 Jun 2015. Available from: URL: http://learningcenter.ehaweb.org/eha/2015/20th/100096/naoki.takezako.biosimilar.filgrastim.for.the.prevention.of.febrile.neutropenia.html?f=l5397p16m3
Rights and permissions
About this article
Cite this article
Biosimilar filgrastim for FN: similar efficacy at lower cost. PharmacoEcon Outcomes News 732, 13 (2015). https://doi.org/10.1007/s40274-015-2279-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2279-3